First Trust Nasdaq Pharmaceuticals ETF (NASDAQ:FTXH) Trading Up 0.6%

Posted by Latisha Jones on Aug 17th, 2024

First Trust Nasdaq Pharmaceuticals ETF (NASDAQ:FTXH – Get Free Report)’s stock price rose 0.6% during trading on Thursday . The stock traded as high as $28.63 and last traded at $28.59. Approximately 1,074 shares traded hands during trading, a decline of 82% from the average daily volume of 5,989 shares. The stock had previously closed at $28.40.

First Trust Nasdaq Pharmaceuticals ETF Stock Up 0.2 %

The stock has a market capitalization of $18.62 million, a price-to-earnings ratio of 15.98 and a beta of 0.70. The business has a 50-day simple moving average of $27.83 and a two-hundred day simple moving average of $27.38.

First Trust Nasdaq Pharmaceuticals ETF Increases Dividend

The company also recently announced a dividend, which was paid on Friday, June 28th. Shareholders of record on Thursday, June 27th were given a $0.1284 dividend. This is an increase from First Trust Nasdaq Pharmaceuticals ETF’s previous dividend of $0.07. The ex-dividend date was Thursday, June 27th.

Institutional Investors Weigh In On First Trust Nasdaq Pharmaceuticals ETF

Institutional investors have recently added to or reduced their stakes in the company. International Assets Investment Management LLC acquired a new stake in First Trust Nasdaq Pharmaceuticals ETF in the second quarter worth approximately $73,000. Ameritas Investment Partners Inc. lifted its position in First Trust Nasdaq Pharmaceuticals ETF by 5.5% in the first quarter. Ameritas Investment Partners Inc. now owns 11,200 shares of the company’s stock worth $314,000 after purchasing an additional 587 shares during the period. Finally, Janney Montgomery Scott LLC acquired a new stake in First Trust Nasdaq Pharmaceuticals ETF in the first quarter worth approximately $1,030,000.

About First Trust Nasdaq Pharmaceuticals ETF

(Get Free Report)

The First Trust Nasdaq Pharmaceuticals ETF (FTXH) is an exchange-traded fund that is based on the Nasdaq US Smart Pharmaceuticals index. The fund tracks the 30 most liquid US pharmaceutical companies, weighted according to factors related to value, volatility, and growth. FTXH was launched on Sep 20, 2016 and is managed by First Trust.